Adjuvant nivolumab following salvage resection in head and neck squamous cell carcinoma patients previously treated with definitive therapy: A single-arm phase II multi-institutional study.

Jennifer L. Leddon, Trisha M. Wise‐Draper, Shuchi Gulati et al.|Journal of Clinical Oncology|2021

Cited by 5